相关实验视频

Updated: Jan 17, 2026

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis

Published on: April 12, 2024

TBA-MLR评分:为术后肝细胞癌的代谢免疫预后生物标志物

Yuanquan Zhao¹, Wei Huang¹, Xiwen Deng²

¹Department of Hepatobiliary, Pancreas and Spleen Surgery, The People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, China.

Frontiers in immunology

|September 22, 2025

概括

结合血清总胆汁酸 (TBA) 和单细胞对淋巴细胞比率 (MLR) 的新预后评分准确地预测了手术后肝细胞癌 (HCC) 患者的结果. 这个TBA-MLR得分识别了传统方法遗漏的高风险患者.

科学领域:

肝胆道手术是肝胆道的手术.
在瘤学瘤学.
代谢和免疫生物标志物

背景情况:

肝细胞癌 (HCC) 仍然是全球癌症死亡的主要原因.
准确的预后分层对于指导HCC患者的术后管理至关重要.
传统的分期系统可能无法完全捕捉HCC的生物复杂性和异质性.

研究的目的:

开发和验证使用血清总胆汁酸 (TBA) 和单细胞对淋巴细胞比率 (MLR) 的新型预后得分.
为了改善肝细胞癌 (HCC) 患者的风险分层,这些患者接受了激进肝切除术.
评估分数在传统的低风险类别中识别高风险患者的能力.

主要方法:

对508名经过彻底肝切除术的HCC患者的回顾性分析.
确定无复发生存期 (RFS) 和总生存期 (OS) 的最佳TBA和MLR截止值.
开发和内部验证使用考克斯回归和引导的三层TBA-MLR风险评分.

主要成果:

升高的TBA和MLR独立预测较差的RFS和OS.
在TBA-MLR得分显著分层患者到不同的低,中,和高风险群体.
该评分确定了BCLC阶段0-A和AFP<400 ng/mL类别中的高风险HCC患者,他们的生存率明显降低.
与传统生物标志物相比,TBA-MLR得分显示出更高的预测准确性 (C指数:RFS 0.639,OS 0.683).

结论:

TBA-MLR评分是一个强大的代谢免疫预后生物标志物,用于HCC.
它有效地揭示了传统分期系统错过的隐秘高风险生物学.
允许精确的术后风险分层,以实现个性化的患者管理.

关键词:

肝细胞癌是肝细胞癌.单细胞与淋巴细胞的比率.预测得分预测得分进行激进肝切除术.总胆汁酸总胆汁酸是什么意思

更多相关视频

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Mass Cytometry Analysis of Systemic and Local Immune Responses in Hepatocellular Carcinoma

Published on: April 25, 2025

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

相关概念视频

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...